Connective Tissue Growth Factor (CTGF, CCN2) Gene Regulation: a Potent Clinical Bio-marker of Fibroproliferative Disease?

Overview

Journal J Cell Commun Signal

Date 2009 Jan 22

PMID 19156539

Citations 101

Authors

Andrew Leask

Sunil K Parapuram

Xu Shi-Wen

D J Abraham

Affiliations

Soon will be listed here.

Abstract

The CCN (cyr61, ctgf, nov) family of modular proteins regulate diverse biological affects including cell adhesion, matrix production, tissue remodelling, proliferation and differentiation. Recent targeted gene disruption studies have demonstrated the CCN family to be developmentally essential for chondrogenesis, osteogenesis and angiogenesis. CCN2 is induced by agents such as angiotensin II, endothelin-1, glucocorticoids, HGF, TGFbeta, and VEGF, and by hypoxia and biomechanical and shear stress. Dysregulated expression of CCN2 has also been widely documented in many fibroproliferative diseases. This mini-review will focus on CCN2, and the recent progress in understanding CCN2 gene regulation in health and disease. That CCN2 should be considered a novel and informative surrogate clinical bio-marker for fibroproliferative disease is discussed.

Citing Articles

Salirasib Inhibits the Expression of Genes Involved in Fibrosis in Fibroblasts of Systemic Sclerosis Patients.

Sadeghi Shaker M, Rokni M, Kavosi H, Enayati S, Madreseh E, Mahmoudi M Immun Inflamm Dis. 2024; 12(11):e70063.

PMID: 39601641 PMC: 11600624. DOI: 10.1002/iid3.70063.

Human amniotic membrane modulates collagen production and deposition in vitro.

Moreno S, Enwerem-Lackland I, Dreaden K, Massee M, Koob T, Harper J Sci Rep. 2024; 14(1):15998.

PMID: 38987293 PMC: 11237048. DOI: 10.1038/s41598-024-64364-2.

Fibroblast Yap/Taz Signaling in Extracellular Matrix Homeostasis and Tissue Fibrosis.

Chu C, Quan T J Clin Med. 2024; 13(12).

PMID: 38929890 PMC: 11204269. DOI: 10.3390/jcm13123358.

Emerging Perspectives of YAP/TAZ in Human Skin Epidermal and Dermal Aging.

Kim J, Quan T Ann Dermatol. 2024; 36(3):135-144.

PMID: 38816974 PMC: 11148314. DOI: 10.5021/ad.23.156.

Positive Regulation of S-Adenosylmethionine on Chondrocytic Differentiation via Stimulation of Polyamine Production and the Gene Expression of Chondrogenic Differentiation Factors.

Hoang L, Aoyama E, Hiasa M, Omote H, Kubota S, Kuboki T Int J Mol Sci. 2023; 24(24).

PMID: 38139122 PMC: 10743985. DOI: 10.3390/ijms242417294.

References

Kantarci A, Black S, Xydas C, Murawel P, Uchida Y, Yucekal-Tuncer B . Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol. 2006; 210(1):59-66. PMC: 1557679. DOI: 10.1002/path.2000. View

Xu S, Howat S, Renzoni E, Holmes A, Pearson J, Dashwood M . Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem. 2004; 279(22):23098-103. DOI: 10.1074/jbc.M311430200. View

Bradham D, Igarashi A, Potter R, Grotendorst G . Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991; 114(6):1285-94. PMC: 2289134. DOI: 10.1083/jcb.114.6.1285. View

Kidd M, Modlin I, Shapiro M, Camp R, Mane S, Usinger W . CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol. 2007; 13(39):5208-16. PMC: 4171302. DOI: 10.3748/wjg.v13.i39.5208. View

Grotendorst G . Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1998; 8(3):171-9. DOI: 10.1016/s1359-6101(97)00010-5. View

Leask A, Holmes A, Black C, Abraham D . Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003; 278(15):13008-15. DOI: 10.1074/jbc.M210366200. View

Higgins D, Biju M, Akai Y, Wutz A, Johnson R, Haase V . Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol. 2004; 287(6):F1223-32. DOI: 10.1152/ajprenal.00245.2004. View

Nguyen T, Tarnow L, Andersen S, Hovind P, Parving H, Goldschmeding R . Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2005; 29(1):83-8. DOI: 10.2337/diacare.29.1.83. View

Gressner O, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner A . Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol. 2008; 49(5):758-67. DOI: 10.1016/j.jhep.2008.03.029. View

10.

Riser B, Cortes P, DeNichilo M, Deshmukh P, Chahal P, Mohammed A . Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int. 2003; 64(2):451-8. DOI: 10.1046/j.1523-1755.2003.00130.x. View

11.

Chen S, McLean S, Carter D, Leask A . The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts. J Cell Commun Signal. 2008; 1(3-4):175-83. PMC: 2443233. DOI: 10.1007/s12079-007-0015-x. View

12.

Huang B, Dornbach L, Lyons K . The 5' untranslated regions (UTRs) of CCN1, CCN2, and CCN4 exhibit cryptic promoter activity. J Cell Commun Signal. 2008; 1(1):17-32. PMC: 2267653. DOI: 10.1007/s12079-007-0003-1. View

13.

Kennedy L, Parapuram S, Greenspoon J, Leask A . Ceramide inhibits CCN2 expression in fibroblasts. J Cell Commun Signal. 2008; 2(1-2):19-23. PMC: 2570009. DOI: 10.1007/s12079-008-0024-4. View

14.

Thomson S, McLennan S, Kirwan P, Heffernan S, Hennessy A, Yue D . Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J Diabetes Complications. 2008; 22(4):284-94. DOI: 10.1016/j.jdiacomp.2007.07.001. View

15.

Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M . Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail. 2008; 10(4):373-9. DOI: 10.1016/j.ejheart.2008.02.011. View

16.

Ito Y, Aten J, Bende R, Oemar B, Rabelink T, Weening J . Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998; 53(4):853-61. DOI: 10.1111/j.1523-1755.1998.00820.x. View

17.

Grotendorst G, Okochi H, Hayashi N . A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 1996; 7(4):469-80. View

18.

Leask A, Denton C, Abraham D . Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol. 2004; 122(1):1-6. DOI: 10.1046/j.0022-202X.2003.22133.x. View

19.

Ricupero D, Rishikof D, Kuang P, Poliks C, Goldstein R . Regulation of connective tissue growth factor expression by prostaglandin E(2). Am J Physiol. 1999; 277(6):L1165-71. DOI: 10.1152/ajplung.1999.277.6.L1165. View

20.

Phanish M, Wahab N, Hendry B, Dockrell M . TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. Nephron Exp Nephrol. 2005; 100(4):e156-65. DOI: 10.1159/000085445. View